# Allergy Therapeutics plc (AGYTF)

> Healthcare · GB · Reports in GBP

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AGYTF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | £ 36.27M | £ -19.91M | £ -14.51M | £ 26.75M | £ 4.25M |
| 2025 | £ 64.51M | £ -40.09M | £ -32.23M | £ 60.09M | £ -38.70M |
| 2024 | £ 57.36M | £ -41.79M | £ -36.93M | £ 30.99M | £ 3.71M |
| 2023 | £ 64.11M | £ -46.34M | £ -37.48M | £ 36.40M | £ -4.78M |
| 2022 | £ 81.54M | £ -15.44M | £ -19.04M | £ 10.53M | £ 38.40M |
| 2021 | £ 103.23M | £ 3.53M | £ 7.29M | £ 11.17M | £ 48.54M |
| 2020 | £ 100.36M | £ 9.06M | £ 12.49M | £ 12.18M | £ 43.78M |
| 2019 | £ 95.39M | £ 4.49M | £ 3.29M | £ 2.44M | £ 37.56M |
| 2018 | £ 89.60M | £ -9.88M | £ -7.61M | £ 3.06M | £ 23.03M |
| 2017 | £ 85.76M | £ -3.32M | £ -1.77M | £ 3.33M | £ 29.97M |
| 2016 | £ 66.64M | £ -17.96M | £ -17.96M | £ 3.37M | £ 30.32M |
| 2015 | £ 60.45M | £ 151.0K | £ 2.84M | £ 1.68M | £ 34.47M |
| 2014 | £ 58.96M | £ 1.04M | £ 1.79M | £ 49.0K | £ 15.08M |
| 2013 | £ 55.59M | £ 895.9K | £ -2.98M | £ 288.0K | £ 14.67M |
| 2012 | £ 59.57M | £ 1.19M | £ 2.34M | £ 1.52M | £ 14.59M |
| 2011 | £ 61.41M | £ -3.93M | £ -4.82M | £ 15.15M | £ 2.14M |
| 2010 | £ 62.39M | £ 897.2K | £ 6.1K | £ 11.71M | £ 3.89M |
| 2009 | £ 59.63M | £ -18.58M | £ -3.41M | £ 30.91M | £ -23.18M |
| 2008 | £ 50.01M | £ -32.72M | £ -35.37M | £ 25.84M | £ -11.29M |
| 2007 | £ 42.77M | £ -38.64M | £ -36.53M | £ 2.16M | £ 8.60M |
| 2006 | £ 40.04M | £ -10.49M | £ -17.50M | £ 0 | £ 32.70M |
| 2005 | £ 36.03M | £ -3.83M | £ -1.68M | £ 455.0K | £ 20.08M |
| 2004 | £ 32.15M | £ 2.18M | £ 2.05M | £ 1.16M | £ 7.08M |
| 2003 | £ 31.47M | £ 9.40M | £ 3.07M | £ 2.11M | £ 5.55M |
| 2002 | £ 27.86M | £ -8.58M | £ -4.30M | £ 9.01M | £ -6.46M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 6.30 |
| Liabilities / Eq | 15.71 |
| Current Ratio | 1.13 |

## Other views

- [Metrics](https://sponda.capital/en/AGYTF.md)
- [Charts](https://sponda.capital/en/AGYTF/charts.md)
- [Compare](https://sponda.capital/en/AGYTF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.